Abstract:Ganoderma triterpenoids (GTs), a class of major active constituents in Ganoderma species, play an important role in the anti-obesity effect of Ganoderma fungi. In the study, seventeen new highly oxygenated lanostane triterpenoids, ganoapplanoids A–Q (1–17), together with five previously reported compounds (18–22), were isolated from the fruiting bodies of Ganoderma applanatum. Their structures were confirmed by comprehensive spectroscopic analyses, single-crystal X-ray diffraction and Mo2(OAc)4 induced CD cotton effect. Structurally, compound 6 represents the first example of 2-norlanostane triterpenoid possessing an unusual semiacetal moiety. Furthermore, isolates (1–5, 7–11, 13–22, 3a) were evaluated for regulatory effects on lipid accumulation by 3T3-L1 adipocytes model. Among them, compounds 11 and 17 exhibited significant potency in blunted adipogenesis activities dose-dependently. Meanwhile, compounds 11 and 17 reduced triglyceride (TG) and total cholesterol (TC) levels in the adipocytes. These results supported that the highly oxygenated lanostane triterpenoids from G. applanatum may serve as agents for inhibiting the lipid accumulation in adipocytes and the G. applanatum provided an important source for searching new drugs to treat obesity.

Insulin Mimetic Lanostane Triterpenes from the Cultivated Mushroom Ganoderma Orbiforme

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Lanostane Triterpenoids with Glucose-Uptake-Stimulatory Activity from Peels of the Cultivated Edible Mushroom Wolfiporia cocos

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Isolation of 3,4-Seco-27-norlanostane Triterpenoids from Cultivated Fruiting Bodies of Ganoderma Orbiforme

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi

Anti-Adipogenic Lanostane-Type Triterpenoids from the Edible and Medicinal Mushroom Ganoderma applanatum

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

Cytotoxic lanostanoid triterpenes from Ganoderma lucidum.

New lanostane-type triterpenoids with proangiogenic activity from the fruiting body of Ganoderma applanatum

New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum

Lanostane Triterpenoids from the Fruiting Bodies of Fomes Officinalis and Their Anti-Inflammatory Activities

Spiroganodermaines A−G from Ganoderma species and their activities against insulin resistance and renal fibrosis

Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase

Highly oxygenated lanostane triterpenoids from Ganoderma applanatum as a class of agents for inhibiting lipid accumulation in adipocytes

Lanostane triterpenoids from Ganoderma lucidum and their inhibitory effects against FAAH

A New Hypoglycemic Prenylated Indole Alkaloid N-Oxide from Endophytic Fungus Pallidocercospora crystalline

Metabolites from the Mushroom Ganoderma Lingzhi As Stimulators of Neural Stem Cell Proliferation.